MindMaze, a global pioneer in AI-driven digital neurotherapeutics, has launched its proprietary medical device Izar in the US and Europe. Izar is a first-of-its-kind, FDA-listed and CE-marked smart peripheral for patients with impairment in hand motor function. Leading global centers in the US, UK and New Zealand are already using the device.
MindMaze is a Switzerland-based digital neuro-therapeutics platform that offers solutions such as virtual reality-enabled brain health and recovery for neurological diseases.